|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
15
|
|
pubmed:dateCreated |
2006-10-12
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Second-generation (atypical) antipsychotic drugs are widely used to treat psychosis, aggression, and agitation in patients with Alzheimer's disease, but their benefits are uncertain and concerns about safety have emerged. We assessed the effectiveness of atypical antipsychotic drugs in outpatients with Alzheimer's disease.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:CATIE-AD Study Group,
pubmed-author:DagermanKaren SKS,
pubmed-author:DavisSonia MSM,
pubmed-author:HsiaoJohn KJK,
pubmed-author:IsmailM SaleemMS,
pubmed-author:LebowitzBarry DBD,
pubmed-author:LiebermanJeffrey AJA,
pubmed-author:LyketsosConstantine GCG,
pubmed-author:RyanJ MichaelJM,
pubmed-author:SchneiderLon SLS,
pubmed-author:StroupT ScottTS,
pubmed-author:SultzerDavid LDL,
pubmed-author:TariotPierre NPN,
pubmed-author:WeintraubDanielD
|
|
pubmed:copyrightInfo |
Copyright 2006 Massachusetts Medical Society.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
12
|
|
pubmed:volume |
355
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1525-38
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:17035647-Aged,
pubmed-meshheading:17035647-Alzheimer Disease,
pubmed-meshheading:17035647-Antipsychotic Agents,
pubmed-meshheading:17035647-Benzodiazepines,
pubmed-meshheading:17035647-Dibenzothiazepines,
pubmed-meshheading:17035647-Double-Blind Method,
pubmed-meshheading:17035647-Female,
pubmed-meshheading:17035647-Humans,
pubmed-meshheading:17035647-Male,
pubmed-meshheading:17035647-Mental Disorders,
pubmed-meshheading:17035647-Proportional Hazards Models,
pubmed-meshheading:17035647-Risperidone,
pubmed-meshheading:17035647-Survival Analysis,
pubmed-meshheading:17035647-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.
|
|
pubmed:affiliation |
Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. lschneid@usc.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
